Selected article for: "risk factor and RSV infection"
Author: Toh, Teck-Hock; Hii, King-Ching; Fieldhouse, Jane K; Ting, Jakie; Berita, Antoinette; Nguyen, Tham Thi; Wong, See-Chang; Wong, Toh-Mee; Lim, Wei-Honn; Ha, Siaw-Jing; Lau, Chuet-Zou; Kong, Sing-Ling; Bailey, Emily S; Warkentien, Tyler E; Husain, Tupur S; Gray, Gregory C
Title: High Prevalence of Viral Infections Among Hospitalized Pneumonia Patients in Equatorial Sarawak, Malaysia
  • Document date: 2019_2_13
    • ID: 08kqtw8s_39
    Snippet: The findings from this study may assist the hospitals in their preparedness for future pneumonia admissions when new antivirals and vaccines are more readily available. Whereas current therapies for RSV infection are largely supportive, as of 2018 there are more than 50 ongoing RSV vaccine trials and 45 RSV antiviral drug trials currently being evaluated, suggesting that new prevention and treatment mechanisms may be on the horizon [2] . The risk.....
    Document: The findings from this study may assist the hospitals in their preparedness for future pneumonia admissions when new antivirals and vaccines are more readily available. Whereas current therapies for RSV infection are largely supportive, as of 2018 there are more than 50 ongoing RSV vaccine trials and 45 RSV antiviral drug trials currently being evaluated, suggesting that new prevention and treatment mechanisms may be on the horizon [2] . The risk factor analysis of age categories and RSV-A detection also provides evidence to support and encourage breastfeeding among newborns.

    Search related documents:
    Co phrase search for related documents
    • current therapy and rsv infection: 1, 2
    • current therapy and treatment prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • current therapy and vaccine trial: 1
    • currently evaluate and treatment prevention: 1, 2, 3
    • currently evaluate and vaccine trial: 1
    • drug trial and treatment prevention: 1, 2, 3, 4, 5
    • drug trial and vaccine trial: 1, 2, 3, 4, 5
    • new antiviral and rsv infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • new antiviral and treatment prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • new antiviral and treatment prevention mechanism: 1
    • new antiviral and vaccine new antiviral: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • pneumonia admission and rsv infection: 1
    • pneumonia admission and treatment prevention: 1
    • risk factor analysis and rsv infection: 1
    • risk factor analysis and treatment prevention: 1, 2
    • risk factor and rsv infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • risk factor and study finding: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • risk factor and treatment prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • risk factor and vaccine trial: 1, 2